Dr. Benjamin Beatty, MD

Dr. Beatty practices at M Health Fairview St. John's Hospital in Maplewood, Minnesota, part of M Health Fairview.

Dr. Beatty's NPI, 1912324823, was assigned on March 28, 2014. Dr. Beatty holds Ohio license 35C.001541.

Dr. Beatty's primary practice is M Health Fairview St. John's Hospital, at 1575 Beam Avenue, Maplewood, MN 55109 in Ramsey County. The practice phone is (651) 232-7000.

Dr. Beatty's primary practice is M Health Fairview St. John's Hospital in Maplewood, Minnesota, part of M Health Fairview. Dr. Beatty is also affiliated with Ohio State University Hospital. The medical group on file is Fairview Health Services. Dmand AI also links Dr. Beatty to 3 more hospitals, 9 medical groups, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beatty practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Beatty's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Beatty's licenses on file in 3 states: Ohio, Colorado and Minnesota.

CMS data shows 458 Medicare services from Dr. Beatty across 6 procedure codes in 2024, for 169 Medicare patients. Medicare paid $39,964 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Beatty in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beatty's median patient age at 75, with 49% women.

In 2024, Dr. Beatty wrote 204 Medicare Part D claims for 91 patients. 87% of them were for generic drugs. CMS names the drug for 37 of them, across 3 drugs with 11 or more claims each, at $7,339 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Beatty for performance year 2024, reported as part of a group. Dr. Beatty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beatty as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Beatty from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $35.